Login | Register

First Vaccine For Potential Treatment Of Parkinson’s

AFFiRiS AG has started the first ever Phase I clinical trial for the development of a Parkinson's vaccine (PD01A) at the Confraternität Privatklinik Josefstadt in Vienna. This is the first time a vaccine has the potential to treat the cause of Parkinson's. The study, supported generously by the US-American Michael J...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *